ABELIOVICH ASA (President & CEO) reported 1 transaction at PREVAIL THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/26/2021ACC: 0001209191-21-005459
DirectorOfficer10% Owner· President & CEO
Since Jun 2019
-4.14M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
4.14M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.39M
Price / share
—
Trade value
—
% of position
New position
1/22/2021
2.39M→0.00
Total
Net shares
−2.39M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2021 | U · U | −2.39M | — | — | New position | 2.39M | 0.00 |
| Total | −2.39M | $0.00 | ||||||
Derivative Transactions3
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.33M shares
Shares
−1.33M
Strike price
0.18
Held after
0.00
Exercisable
—
1/22/2021
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
178.68K shares
Shares
−178.68K
Strike price
10.26
Held after
0.00
Exercisable
—
1/22/2021
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
250K shares
Shares
−250K
Strike price
16.91
Held after
0.00
Exercisable
—
1/22/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.33M shares | 1/22/2021 | D · Disposition | −1.33M | 0.18 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock178.68K shares | 1/22/2021 | D · Disposition | −178.68K | 10.26 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock250K shares | 1/22/2021 | D · Disposition | −250K | 16.91 | — | 0.00 |